Literature DB >> 16121513

Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections.

M Narimanian1, M Badalyan, V Panosyan, E Gabrielyan, A Panossian, G Wikman, H Wagner.   

Abstract

The clinical efficacy of KanJang oral solution, a fixed combination of standardised extracts of Echinacea purpurea, Adhatoda vasica and Eleutherococcus senticosus, was compared with the combined extracts of Echinacea purpurea and Eleutherococcus senticosus alone (Echinacea mixture) in a controlled, double blind, randomized trial, and with Bromhexine (a standard treatment) in a controlled, open, randomized clinical trial on patients with non-complicated acute respiratory tract infections. Many of the parameters evaluated, such as severity of coughing, frequency of coughing, efficacy of mucus discharge in the respiratory tract, nasal congestion and a general feeling of sickness, showed significantly greater improvement in patients treated with KanJang compared with those receiving the standard treatment. However, no significant differences in the improvement of these symptoms (except in a reduced frequency of coughing) were observed between patients treated with the Echinacea mixture and those receiving the standard treatment. The only explanation is that the lack of extract of A. vasica in the Echinacea mixture reduces its efficacy compared with the complete KanJang oral solution even though direct double-blind comparison yielded no significant differences between these two groups of patients. The recovery time of patients being treated with KanJang or Echinacea mixture was 2 days shorter than that of patients receiving the standard treatment. None of the patients completing the study reported adverse reactions to the medication taken. The significance of the results obtained in this study is discussed with respect to the efficacy of KanJang in the treatment of acute respiratory infection and to the concept that multi-drug therapy offers higher efficacy compared with mono-drug treatment of such infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16121513     DOI: 10.1016/j.phymed.2004.10.001

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Impact of drinking water supplementation of a blend of peppermint, coneflower (Echinacea purpurea), thyme, propolis, and prebiotic on performance, serum constituents, and immunocompetence of broiler chickens.

Authors:  Hamid Reza Behboodi; Davood Hosseini; Asadollah Salarieh; Mahmood Gholampour; Masoud Panahi; Morteza Alemi; Atefeh Baradaran; Hadi Haghbin Nazarpak
Journal:  Trop Anim Health Prod       Date:  2022-09-10       Impact factor: 1.893

Review 2.  Echinacea for preventing and treating the common cold.

Authors:  Marlies Karsch-Völk; Bruce Barrett; David Kiefer; Rudolf Bauer; Karin Ardjomand-Woelkart; Klaus Linde
Journal:  Cochrane Database Syst Rev       Date:  2014-02-20

Review 3.  In vitro biotechnological advancements in Malabar nut (Adhatoda vasica Nees): Achievements, status and prospects.

Authors:  Saikat Gantait; Jitendriya Panigrahi
Journal:  J Genet Eng Biotechnol       Date:  2018-03-19

Review 4.  Current Prevention of COVID-19: Natural Products and Herbal Medicine.

Authors:  Junqing Huang; Gabriel Tao; Jingwen Liu; Junming Cai; Zhongyu Huang; Jia-Xu Chen
Journal:  Front Pharmacol       Date:  2020-10-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.